| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
| 03/14/2007 | EP1565433B1 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/13/2007 | US7189873 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 03/08/2007 | WO2007025999A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/08/2007 | CA2620022A1 Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with staphylococcus aureus |
| 03/01/2007 | WO2007024869A2 Catalyst for making fluoroelastomer compositions and methods of using the same |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/15/2007 | WO2006113606A3 Histone deacetylase inhibitors |
| 02/15/2007 | US20070037785 Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/14/2007 | EP0946478B1 Process for the solid phase synthesis of aldehydes, ketones and hydroxamic acid compounds |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/01/2007 | US20070027260 Monoamidine-based, bisamidine-based, and monoamidoxime-based curatives, co-curatives and cure accelerators for perfluoroelastomeric compositions; co-curatives and cure accelerators having high molecular weight |
| 02/01/2007 | US20070027112 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 01/31/2007 | EP1748046A2 Inhibitors of histone deacetylase |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/30/2007 | US7169816 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 01/30/2007 | US7169808 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/25/2007 | WO2006123051A3 P-tert-butylcalix[6]arenes with triacidic functions at 2, 4 and 6 supported liquid membranes support materials comprising the same and use thereof |
| 01/25/2007 | US20070021612 Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof |
| 01/24/2007 | EP1745022A1 Histone deacetylase inhibitor prodrugs |
| 01/24/2007 | EP1549609B1 Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms |
| 01/24/2007 | CN1901895A Methods of treating cancer with hdac inhibitors |
| 01/18/2007 | CA2614930A1 Glutamate aggrecanase inhibitors |
| 01/18/2007 | CA2613458A1 Compounds with activity at retinoic acid receptors |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/11/2007 | US20070010669 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/11/2007 | US20070010536 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 01/11/2007 | CA2613860A1 Novel hydroxamic acid-containing amino acid derivatives |
| 01/04/2007 | WO2007000383A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives |
| 01/04/2007 | US20070004806 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 01/03/2007 | CN1889922A Use of osteopontin in dental formulations |
| 01/03/2007 | CN1293067C Process for preparing discodermolid and analogues thereof |
| 01/03/2007 | CN1293049C N-hydroxyformamidine derivative |
| 01/02/2007 | CA2218892C Diaromatic propynyl or dienyl compounds |
| 12/26/2006 | US7154002 Phenylglycinamide derivatives containing a substituent capable of complexing with a protein metal ion, particularly an acrylhydroxamic group, e.g., 3-(3-{Benzylcarbamoyl-[formyl-(4-phenoxy-phenyl)-amino]-methyl}-phenyl)-N-hydroxy-acrylamide; antiproliferative agents |
| 12/21/2006 | WO2006134469A1 Methods of preparing mek inhibitor |
| 12/21/2006 | US20060287280 N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; zinc metallopeptidase inhibitors; promoting faster regeneration of bone mass after bone fractures, implantation of orthopedic and dental prostheses; osteogenesis stimulant; control phosphate metabolism |
| 12/20/2006 | EP1461308B1 Bacterial enzyme inhibitors |
| 12/14/2006 | US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals |
| 12/13/2006 | CN1289472C Hydroxamic acid derivatives and medicinal utilization thereof |
| 12/12/2006 | US7148259 hydroxyamidines; antibiotic resistance |
| 12/12/2006 | US7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid |
| 12/12/2006 | US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders |
| 12/12/2006 | US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 12/12/2006 | US7148198 Antibacterial agents |
| 12/07/2006 | US20060276409 N-Hydroxy-N-(1-(2-carbamoylalkylaminocarbonyl)ethyl)formamides: [(Formyl-hydroxy-amino)-methyl]-3-cyclopentyl-propionic acid (1-dimethyl-carbamoyl-2,2-dimethyl-propyl)-amide; bacterial polypeptide deformylase inhibitors |
| 12/05/2006 | CA2189652C Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| 11/30/2006 | US20060270651 Antibacterial agents |
| 11/30/2006 | CA2606565A1 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 11/29/2006 | EP1726589A2 5,5'-bis-(4-amidinophenyl)-2,2'-bifuran derivatives and related compounds as antiprotozoal agent and prodrugs thereof |
| 11/29/2006 | EP1726580A1 Aminophenylpropanoic acid derivative |
| 11/22/2006 | CN1867543A Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
| 11/21/2006 | CA2120619C Novel potent inducers of terminal differentiation and methods of use thereof |
| 11/14/2006 | US7135593 Biocompatible polymeric materials for medical implant devices |
| 11/09/2006 | WO2006117549A1 Enzyme inhibitors |
| 11/09/2006 | WO2006117548A1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 11/09/2006 | WO2006025978A3 Non-antibiotic intervention of chlamydial infection |
| 11/09/2006 | US20060252834 Anti-aging skin care; e.g. N-[4-(N-hydroxycarbamoyl)phenyl]benzamide; inhibits collagenase and/or elastase expression; less skin irritation than conventional retinoic acid |
| 11/09/2006 | CA2599411A1 Enzyme inhibitors |
| 11/02/2006 | US20060247289 Certain chemical entities, compositions, and methods |
| 11/02/2006 | EP1301458A4 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 10/31/2006 | US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor |
| 10/26/2006 | US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 10/25/2006 | EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 10/25/2006 | CN1852737A Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 10/24/2006 | US7126001 Antiproliferative agents; antitumor agents |
| 10/24/2006 | US7125910 Compounds and compositions for delivering active agents |
| 10/24/2006 | US7125871 Excitatory amino acid receptor modulators |
| 10/24/2006 | CA2262451C Boronic compound complexing reagents and complexes |
| 10/24/2006 | CA2237650C Benzamidoxime prodrugs as antipneumocystic agents |
| 10/18/2006 | CN1849300A Method for producing N,N -dialkoxy-N,N -dialkyl oxamide |
| 10/11/2006 | EP1710238A1 Benzophenones as inhibitors of reverse transcriptase |
| 10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 10/04/2006 | EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative |
| 10/03/2006 | US7115605 Peptide deformylase inhibitors |
| 09/28/2006 | WO2005016240A3 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 09/27/2006 | CN1839115A Hydroxamic acid derivatives and the method for preparing thereof |
| 09/21/2006 | WO2006097279A1 Amidrazone compounds for combating animal pests |
| 09/20/2006 | EP1660437A4 Hydroxamic acid derivatives and the method for preparing thereof |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/14/2006 | WO2005037257A3 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1696898A2 Zn 24 -chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101900 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 08/31/2006 | WO2006090153A1 Process for preparing protected amiidines |
| 08/31/2006 | CA2598496A1 Process for preparing protected amiidines |
| 08/30/2006 | EP1694678A2 Process for preparing hexahydropyrimido 1,2-a¨azepine-2-carboxylates and related compounds |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |